Lianos E A, Rahman M A, Dunn M J
J Clin Invest. 1985 Oct;76(4):1355-9. doi: 10.1172/JCI112110.
Arachidonate lipoxygenation to monohydroxylated eicosatetraenoic acids (HETE) was studied in rat nephrotoxic serum nephritis (NSN). A single infusion of nephrotoxic serum enhanced conversion of [3H]arachidonic acid ([3H]C20:4) to [3H]12-HETE in glomeruli isolated from nephritic rats compared with controls. The percent conversion of [3H]arachidonic acid was 1.95 +/- 0.2% in control glomeruli and 14.2 +/- 2% in nephritic glomeruli 2 d after induction of disease. No significant changes in the conversion of [3H]C20:4 to [3H]5-, 8-, and 9-HETE were noted. Extraction of glomerular HETE by alkaline hydrolysis, to evaluate possible reacylation of HETE after their production, confirmed the presence of 12-HETE and did not provide evidence of 5-HETE synthesis. Increased glomerular 12-HETE synthesis in nephritic rats was also demonstrated by high pressure liquid chromatography-UV detection and by 12-HETE radioimmunoassay. The enhanced glomerular 12-HETE synthesis commenced as early as 3-5 h after administration of nephrotoxic serum and peaked at day 2 with 10-fold enhancement of 12-HETE production. Increments of glomerular 12-HETE persisted on day 7 and returned toward control levels by day 14. Platelet depletion, induced by antiplatelet antisera, did not decrease glomerular 12-HETE synthesis in NSN, thereby eliminating platelets as the cellular origin of 12-HETE. Glomerular epithelial and mesangial cells are the most likely sources of enhanced 12-lipoxygenase activity. The enhanced arachidonate 12-lipoxygenation in glomerular immune injury could have important proinflammatory effects in the evolution of glomerulonephritis since 12-HETE has important effects on leukocyte function.
在大鼠肾毒性血清肾炎(NSN)中研究了花生四烯酸向单羟基化二十碳四烯酸(HETE)的脂氧合作用。与对照组相比,单次输注肾毒性血清可增强从患肾炎大鼠分离的肾小球中[3H]花生四烯酸([3H]C20:4)向[3H]12-HETE的转化。在疾病诱导后2天,对照肾小球中[3H]花生四烯酸的转化率为1.95±0.2%,患肾炎肾小球中为14.2±2%。未观察到[3H]C20:4向[3H]5-、8-和9-HETE转化的显著变化。通过碱性水解提取肾小球HETE,以评估HETE产生后可能的再酰化作用,证实了12-HETE的存在,未提供5-HETE合成的证据。高压液相色谱-紫外检测和12-HETE放射免疫测定也证实了患肾炎大鼠肾小球中12-HETE合成增加。肾小球12-HETE合成增强最早在给予肾毒性血清后3-5小时开始,在第2天达到峰值,12-HETE产量增加10倍。肾小球12-HETE在第7天持续增加,到第14天恢复到对照水平。抗血小板抗血清诱导的血小板耗竭并未降低NSN中肾小球12-HETE的合成,从而排除了血小板作为12-HETE的细胞来源。肾小球上皮细胞和系膜细胞最有可能是12-脂氧合酶活性增强的来源。肾小球免疫损伤中花生四烯酸12-脂氧合作用增强可能在肾小球肾炎的发展中具有重要的促炎作用,因为12-HETE对白细胞功能有重要影响。